EUVIMEDEUVIMED entdecken
VergleichsstudieStudienprotokoll

Comparison of highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone use in patients undergoing in vitro fertilization with progestin-primed ovarian stimulation protocol: a single center retrospective analysis

Selçuk Yetkinel iD, Pınar Çağlar Aytaç, Gülşen Doğan Durdağ, Didem Alkaş Yağınç, Esra Bulgan Kılıçdağ, Erhan Şimşek

Archives of Gynecology and Obstetrics · 02.10.2024 · 310 (5) · 2657-2662

DOI: 10.1007/s00404-024-07756-z ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 02.10.2024. Verfasst von Selçuk Yetkinel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reproductive Endocrinology and IVF Unit of the Başkent University Obstetrics and Gynecology Clinic of the Başkent University Adana Dr. Tu…. Hauptthemen laut MEDLINE: Ovulation Induction, Fertilization in Vitro, Menotropins, Follicle Stimulating Hormone. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Recently, progesterone has been used to prevent LH surge instead of GnRH analogues during ART treatments, which is known as progesterone-primed ovarian stimulation (PPOS) protocol. During ART treatment, highly purified human menopausal gonadotropin (HP-hMG) and recombinant follicle stimulating hormone (rFSH) are two of the agents used for stimulation of antral follicles. The aim of this study is to compare the efficacy and success of HP-hMG and rFSH agents in the ovarian stimulation step of the PPOS protocol, which has not been previously reported in the literature. METHODS: This retrospective study was conducted at a university hospital with patients who underwent IVF treatment using PPOS protocols in between January 2019 and July 2021. For ovarian stimulation, rFSH was used in group I and HP-hMG was used in group II. Mature oocyte ratio was the primary outcome, and live birth rate was the secondary outcome. Mann-Whitney and Chi-square tests were used for statistical analysis. All p values below 0.05 were considered significant. RESULTS: Total numbers of follicles, oocytes, MII, and 2PN numbers obtained were similar between the two groups. The fertilization rates were 66.7% in the rFSH group and 64.3% in the HP-hMG group (p > 0.05). The pregnancy rates were 53.5% and 46.7% in the rFSH and HP-hMG groups, respectively. There was no statistically significant difference between pregnancy, abortus, and live birth rates. CONCLUSION: In this study, it is demonstrated that stimulation of oocytes with either rFSH or hMG in the PPOS protocol, which has been added to IVF treatment protocols in recent years, had no statistical difference regarding mature oocyte numbers and live birth rates between the two groups. These results are consistent with the previous literature which compared rFSH and hMG in GnRH agonist and antagonist protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovulation InductionFertilization in VitroMenotropinsFollicle Stimulating HormoneHumansFemaleRetrospective StudiesAdultPregnancyPregnancy RateRecombinant ProteinsProgesteroneProgestinsLive Birth

Stichwörter der Autor:innen

HP-hMGLive birthOocytePPOSrFSH

Substanzen

MenotropinsFollicle Stimulating HormoneRecombinant ProteinsProgesteroneProgestins

Autor:innen und Institutionen

  • Division of Reproductive Endocrinology and IVF Unit of the Başkent University Obstetrics and Gynecology Clinic of the Başkent University Adana Dr. Turgut Noyan Research and Application Center, Kazım Karabekir Mah. Gülha…
  • Esra Bulgan Kılıçdağ Clinic, Adana, Turkey.

ORCID-Profile: Selçuk Yetkinel

Zitieren

APA

Yetkinel, S., Aytaç, P. Ç., Durdağ, G. D., Yağınç, D. A., Kılıçdağ, E. B., & Şimşek, E. (2024). Comparison of highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone use in patients undergoing in vitro fertilization with progestin-primed ovarian stimulation protocol: a single center retrospective analysis. Archives of Gynecology and Obstetrics, 310(5), 2657-2662. https://doi.org/10.1007/s00404-024-07756-z

Vancouver

Yetkinel S, Aytaç PÇ, Durdağ GD, Yağınç DA, Kılıçdağ EB, Şimşek E. Comparison of highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone use in patients undergoing in vitro fertilization with progestin-primed ovarian stimulation protocol: a single center retrospective analysis. Archives of Gynecology and Obstetrics. 2024;310(5):2657-2662. doi:10.1007/s00404-024-07756-z

BibTeX
@article{Yetkinel2024,
  author = {Yetkinel, Selçuk and Aytaç, Pınar Çağlar and Durdağ, Gülşen Doğan and Yağınç, Didem Alkaş and Kılıçdağ, Esra Bulgan and Şimşek, Erhan},
  title = {Comparison of highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone use in patients undergoing in vitro fertilization with progestin-primed ovarian stimulation protocol: a single center retrospective analysis},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2024},
  volume = {310},
  number = {5},
  pages = {2657--2662},
  doi = {10.1007/s00404-024-07756-z}
}
Kostenlos starten →